-
Mashup Score: 3Validate User - 2 month(s) ago
We are sorry, but we are experiencing unusual traffic at this time. Please help us confirm that you are not a robot and we will take you to your
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
In a 12-2 vote, members of the #FDA's Oncologic Drugs Advisory Committee voted in favor of #imetelstat as a treatment for #anemia in patients with lower-risk #myelodysplastic syndromes (#MDS). https://t.co/fIxXKMKgHr